| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS44027303 | HTLV-1 | ENSG00000140675.13 | protein_coding | SLC5A2 | No | No | 6524 | P31639 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | SLC5A2 |
|---|---|
| DrugBank ID | DB08907 |
| Drug Name | Canagliflozin |
| Target ID | BE0004753 |
| UniProt ID | P31639 |
| Regulation Type | inhibitor |
| PubMed IDs | 23590413 |
| Citations | Lamos EM, Younk LM, Davis SN: Canagliflozin , an inhibitor of sodium-glucose cotransporter 2, for the treatment of type 2 diabetes mellitus. Expert Opin Drug Metab Toxicol. 2013 Jun;9(6):763-75. doi: 10.1517/17425255.2013.791282. Epub 2013 Apr 17. |
| Groups | Approved |
| Direct Classification | Phenolic glycosides |
| SMILES | [H][C@]1(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C1=CC=C(C)C(CC2=CC=C(S2)C2=CC=C(F)C=C2)=C1 |
| Pathways | |
| PharmGKB | |
| ChEMBL | CHEMBL2048484 |
